跳至主要内容
临床试验/JPRN-UMIN000037373
JPRN-UMIN000037373已完成未知

Chemotherapy for recurrence of postoperative colorectal cancer in our institute - Chemotherapy for recurrence of postoperative colorectal cancer

Sapporo City General Hospital0 个研究点目标入组 203 人开始时间: 2019年7月15日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
203

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18years-old 至 90years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • The cases that colorectal cancer patients had not received chemotherapy after R0 resection

研究者

相似试验

尚未招募
2 期
Chemoradiation followed by maintenance therapy for patients with locally advanced cutaneous angiosarcomaCutaneous angiosarcoma
JPRN-UMIN000014397niversity of Tsukuba60
已完成
2 期
Clinical trial of postoperative chemotherapy with TS-1 in recurrent high-risk cases with oral squamous cell carcinomaOral squamous cell carcinoma
JPRN-UMIN000009628Department of Clinical Oral Oncology, Unit of Translational Medicine, Nagasaki University Graduate School of Biomedical Sciences90
进行中(未招募)
不适用
Treatment of the haematological relapse in patients suffering from acute myeloid leukaemia or myelodysplastic syndrome with 5-Azacytidin (Vidaza®) after hematopoietic stem cell transplantation RELAZA - RELAZA
EUCTR2006-001040-31-DEniversity of Technology Dresden
进行中(未招募)
1 期
A phase II clinical trial for patients with node-negative stage I-II intermediate or high risk endometrial cancer where the patients will be divided into 2 groups; chemotherapy after surgery versus observation only.ode-negative stage I-II intermediate or high risk endometrial cancerMedDRA version: 21.0Level: PTClassification code 10014738Term: Endometrial cancer stage ISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: PTClassification code 10014739Term: Endometrial cancer stage IISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2010-023081-52-DEDanish Gynaecological Cancer Group240
进行中(未招募)
1 期
A phase II clinical trial for patients with node-negative stage I-II intermediate or high risk endometrial cancer where the patients will be divided into 2 groups; chemotherapy after surgery versus observation only.ode-negative stage I-II intermediate or high risk endometrial cancerMedDRA version: 21.0Level: PTClassification code 10014738Term: Endometrial cancer stage ISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: PTClassification code 10014739Term: Endometrial cancer stage IISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2010-023081-52-BEDanish Gynaecological Cancer Group240